Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery.
about
New developments in aminoglycoside therapy and ototoxicityStructure of the Response Regulator PhoP from Mycobacterium tuberculosis Reveals a Dimer through the Receiver DomainThe structural and mutational analyses of O-ureido-L-serine synthase necessary for D-cycloserine biosynthesisActivity of trifluoperazine against replicating, non-replicating and drug resistant M. tuberculosisIn vitro activity of rifampicin and verapamil combination in multidrug-resistant mycobacterium tuberculosisA Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, RussiaAntibacterial studies of cationic polymers with alternating, random, and uniform backbones.Streptomycin ototoxicity in rat cochlear organotypic cultures.The prrAB two-component system is essential for Mycobacterium tuberculosis viability and is induced under nitrogen-limiting conditionsMycobacterium tuberculosis thymidylate synthase gene thyX is essential and potentially bifunctional, while thyA deletion confers resistance to p-aminosalicylic acid.Δ1-pyrroline-5-carboxylate reductase as a new target for therapeutics: inhibition of the enzyme from Streptococcus pyogenes and effects in vivoA novel indigoid anti-tuberculosis agent.Emerging paradigms in anti-infective drug design.Antimycobacterial Activities of Endolysins Derived From a Mycobacteriophage, BTCU-1.Toward the total synthesis of elisapterosin B: A Hg(OTf)(2)-promoted diastereoselective intramolecular Friedel-Crafts alkylation reaction.Establishment of an in vitro D-cycloserine-synthesizing system by using O-ureido-L-serine synthase and D-cycloserine synthetase found in the biosynthetic pathway.Synthesis and evaluation of 6-aza-2'-deoxyuridine monophosphate analogs as inhibitors of thymidylate synthases, and as substrates or inhibitors of thymidine monophosphate kinase in Mycobacterium tuberculosis.
P2860
Q24599985-4C7FA4FD-8DB4-4AD9-AA47-BF7406419433Q27668141-6BEE98AD-6FD1-47B1-BEBF-52DE20074367Q27701627-1FBB7B14-B079-4BAE-8478-2204C85DF37FQ28483265-0C43E9AB-9FD1-4F5E-8CC9-223FE1412FD7Q28543447-5E20AE43-1DDB-4B34-B689-C367E1CF66AFQ28554618-0EB4F412-AED2-44F2-8993-AE10E1890232Q35053375-86F12C2A-CF89-4DC8-8556-DCE407C79464Q35373505-90F4DD2D-CA0D-480E-BEE9-6AE3E1BE0C0BQ35668167-B4222925-57BC-4D4D-94E8-9634FC6CFD03Q35960308-B39E2BCC-2204-45DC-BDA7-62ED66C1910FQ37332797-DC05856B-702C-4159-951E-D2B924DC5D0AQ37581199-DA794485-4A71-4C12-83BC-8A1BA6B0FD6BQ38894544-9F017F41-EC2A-4436-8135-AA34767528F8Q40387314-1AF5C719-ABF5-4C3B-8804-4AEB824B3B5CQ41891854-3A28637D-A7A2-4CF1-87FD-9D2700196A87Q42110222-FAED8224-D91B-4C6C-B9D5-A5E171A7D27FQ54523118-E6439EAF-3084-4A54-8555-AA3760C8457F
P2860
Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Extensively Drug-Resistant Tub ...... s for Antimicrobial Discovery.
@ast
Extensively Drug-Resistant Tub ...... s for Antimicrobial Discovery.
@en
Extensively Drug-Resistant Tub ...... s for Antimicrobial Discovery.
@nl
type
label
Extensively Drug-Resistant Tub ...... s for Antimicrobial Discovery.
@ast
Extensively Drug-Resistant Tub ...... s for Antimicrobial Discovery.
@en
Extensively Drug-Resistant Tub ...... s for Antimicrobial Discovery.
@nl
prefLabel
Extensively Drug-Resistant Tub ...... s for Antimicrobial Discovery.
@ast
Extensively Drug-Resistant Tub ...... s for Antimicrobial Discovery.
@en
Extensively Drug-Resistant Tub ...... s for Antimicrobial Discovery.
@nl
P2860
P356
P1433
P1476
Extensively Drug-Resistant Tub ...... s for Antimicrobial Discovery.
@en
P2093
Shelley E Haydel
P2860
P304
P356
10.3390/PH3072268
P577
2010-07-01T00:00:00Z